Optimization of Conoid Anatomical Reconstruction During Ligamentoplasty for Acromioclavicular Dis… (NCT07269418) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Optimization of Conoid Anatomical Reconstruction During Ligamentoplasty for Acromioclavicular Disjunction
France36 participantsStarted 2024-03-28
Plain-language summary
This is a prospective, longitudinal, multicenter, observational cohort study conducted on a population of patients who underwent ligamentoplasty for an acromioclavicular dislocation and who agreed to be followed for a period of two years starting from the day of hospital discharge.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female aged 18 to 60
* Patient who has been informed of the objectives and conditions of the study and who has not objected to participation
* Patient who has undergone reconstruction for an acute Rockwood stage 4 or 5 acromioclavicular dislocation and for whom elbow immobilization was required for 6 weeks (self-rehabilitation in the supine position is possible from day 15, without pendulum or adduction movements).
Exclusion Criteria:
* Time between trauma and ACL reconstruction greater than 10 days
* History of surgery or trauma to the operated shoulder
* History of acromioclavicular surgery or trauma to the contralateral shoulder
* History of shoulder stiffness
* Patient playing a contact sport (rugby, American football)
* Presence of severe acromioclavicular osteoarthritis
* Mental impairment or any other reason that may hinder understanding or strict application of the protocol
* Patient under legal protection, guardianship, or curatorship
* Patient already included in an interventional therapeutic trial
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Acromioclavicular reduction
Timeframe: Month 3
Trial details
NCT IDNCT07269418
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche